ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2025
Time-varying comparative effectiveness of surgical or percutaneous revascularization on patient-centred outcomes.
Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundLittle is known about the comparative risks and timing of patient-defined adverse cardiovascular and noncardiovascular events (PACE) after coronary artery revascularization. We investigated comparative risks of PACEs after coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI).
methodsWe conducted a retrospective cohort study of patients who underwent isolated index myocardial revascularization procedures between Oct. 1, 2008, and Dec. 31, 2018, in Ontario, Canada. The primary exposure was revascularization by CABG or PCI. The primary outcome was PACE, a composite of postoperative severe stroke, ventilator dependence, new-onset or worsening heart failure, long-term care admission, and new-onset dialysis. We modelled the association of revascularization strategy and PACE using an overlap-weighted, cause-specific hazard model, with death as a competing risk.
resultsOf 140 519 patients included in the analysis, 54 018 (38.4%) underwent CABG and 86 501 (61.6%) underwent PCI. The groups were well balanced after overlap weighting. During a median follow-up duration of 4.8 (interquartile range 2.5 to 7.6) years, a total of 22 926 (16.3%) patients experienced PACE, including 9725 (18.0%) in the CABG group and 13 201 (15.3%) in the PCI group. We found no significant between-group difference in the cumulative incidence of PACE over the entire study period (average hazard ratio [HR] 0.97, 95% confidence interval 0.94 to 1.01). However, the HR for PACE varied over time. The HR comparing CABG to PCI was elevated in the first year, reached a minimum of around 0.7 at years 3 and 4, and then rose, favouring PCI again after year 8.
interpretationThe comparative risk of PACE after CABG versus PCI varied significantly over time. These findings provide granular data to support physicians and patients engaged in shared decision-making about revascularization strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.